0
     

Report Added
Report already added
Global Hearing Healthcare (Hearing Aid, Hearing Implant & Hearing Diagnostic) Market Outlook 2022

Global Hearing Healthcare (Hearing Aid, Hearing Implant & Hearing Diagnostic) Market Outlook 2022

Hearing loss also known as hearing impairment refers to partial or total inability to hear. Worldwide, it is a leading cause of disability especially amongst the older population. Hearing healthcare refers to range of products and services intended to restore hearing impairment. It encompasses market segments such as Hearing Aids, Hearing Implants and Diagnostic Instruments. Hearing Aids are sound-amplifying devices, designed to aid people with hearing impairment. It consists of hearing instruments and accessories. Hearing Implants are electronic medical devices which stimulates the auditory nerve bypassing damaged ear. It consists of bone-anchored hearing systems, middle ear and cochlear implants. Hearing Diagnostics Instruments refers to wide range of hearing related equipment which helps in enhancement of hearing.

Growth of global hearing healthcare market is primarily driven by global ageing population, as progressive age-related hearing loss (ARHL) affects hearing ability in older people. There are higher instances of noise-induced hearing loss in younger population. Additionally, global hearing healthcare market highly underpenetrated with exception few Western countries with higher levels of reimbursement. This factors are leading contributors to progression of global hearing healthcare market. Various restraints to development of global hearing healthcare market are social stigma associated with use of hearing aid, lack of awareness and high prices.

The report “Global Hearing Healthcare (Hearing Aid, Hearing Implant & Hearing Diagnostic) Market Outlook 2022” provides information on the current scenario, detailed market outlook of the global as well as major hearing healthcare markets such as Germany, France and the UK in European region and the US in North America. The report encompasses detailed analysis of major segments of hearing healthcare industry - Hearing Aid, Hearing Implant (Cochlear and Bone Anchored) and Hearing Diagnostic. Future forecasts of hearing healthcare market overall and across various sub-segments till 2022 is provided in the report. Furthermore, major industry players, both international and domestic, have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major international industry players operating in the global hearing healthcare industry include William Demant Holding Group, GN Store Nord, Sonova Holdings AG and Amplifon Corporate. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as major hearing healthcare markets.

1. Executive Summary
2. Research Methodology
3. Hearing Healthcare
3.1 Overview
3.1.1 Types of Hearing Loss
3.1.2 Causes of Hearing Loss
3.2 Market Segmentation
3.2.1 Hearing Aid
3.2.2 Hearing Implants
3.2.3 Hearing Diagnostics
3.3 Distribution Channel
3.4 Value Chain Analysis
3.4.1 Hearing Aid Value Chain
3.4.2 Hearing Implant Value Chain
3.4.3 Hearing Diagnostic Value Chain
3.5 Market Analysis
3.5.1 Market Size by Value
3.5.2 Market Share by Segments
3.5.3 Market Share by Region
3.5.4 Market Share by Nations
4. Global Hearing Healthcare Market Segmentation
4.1 Hearing Aid
4.1.1 Market Size by Value
4.1.2 Market Size by Volume
4.1.3 Market (Value) Share by Distribution Channel
4.1.4 Market (Volume) Share by Distribution Channel
4.2 Hearing Implants
4.2.1 Cochlear Implant
4.2.1.1 Cochlear Implant Market Size by Value
4.2.1.2 Cochlear Implant Market Size by Volume
4.2.1.3 Cochlear Implants Market Share by Region
4.2.1.4 Cochlear Implants Market Share by Competitors
4.2.2 Bone-Anchored Hearing Implants
4.2.2.1 Market Size by Value
4.2.2.2 Market Share by Competitors
4.2.3 Middle Ear Implant
4.3 Hearing Diagnostic Instruments
4.3.1 Overview
4.3.2 Market Size by Value
5. Europe Hearing Aids Market Analysis
5.1 Market Sizing
5.1.1 Market Size by Volume (Actual & Forecasted)
5.1.2 Market Size by Value (Actual & Forecasted)
5.2 Market Segmentation
5.2.1 Behind-the-Ear (BTE) Hearing Aid
5.2.2 In-the-Ear (ITE) Hearing Aid
5.2.3 Receiver-in-the-Ear (RITE) Hearing Aid
5.2.4 Canal Hearing Aids
5.3 Distribution Channel
6. Europe Hearing Aid Market: Country Analysis
6.1 France Hearing Aid Market
6.1.1 Overview
6.1.2 Market Size by Volume
6.1.3 Distribution Channel
6.1.4 Market Share by Competitors
6.2 Germany Hearing Aid Market
6.2.1 Overview
6.2.2 Market Size by Volume
6.2.3 Distribution Channel
6.2.4 Market Share by Competitors
6.3 The UK Hearing Aid Market
6.3.1 Overview
6.3.2 Distribution Channel
7. North America
7.1 Overview
7.2 Market Analysis
7.2.1 Market Size by Volume
7.3 Distribution Channel
7.4 The US
7.4.1 Overview
7.4.2 Market Size by Volume
7.4.3 Market Share by Type of Hearing Aid
7.4.4 Distribution Channel
8. Global Hearing Aid Pricing Analysis
10. Global Hearing Healthcare Market Dynamics
10.1 Industry Trends & Developments
10.1.1 Smart Earbuds
10.1.2 Advent of World’s First Internet of Things Hearing Aid
10.1.3 Shift in Channel Mix- towards High Volume Retailers
10.1.4 Consolidation in the Hearing Aid Industry
10.1.5 Dominance of OECD Countries
Figure 65: Global Hearing Aids Market (Value) Split OECD and Non-OECD Countries (2016)
10.1.6 World’s First Li-ion Rechargeable Hearing Aids
10.1.7 Over-the-Counter Hearing Aid Act of 2017
10.2 Growth Drivers
10.2.1 Aging Demographic
10.2.2 Prevalence of Hearing Loss
10.2.3 Low Market Penetration
10.2.4 Other Drivers
10.3 Challenges
10.3.1 Hearing Aid Stigma
10.3.2 Lack of Uptake of Hearing Aids
10.3.3 High Prices
11. Competitive Landscape
11.1 Market Share by Competitors
11.1.1 Global Hearing Aids Market Share
11.1.2 The US Hearing Aids Market Share
11.1.3 France Hearing Aids Market Share
11.1.4 Germany Hearing Aids Market Share
11.1.5 The UK Hearing Aids Market Share
11.2 Financial Analysis
11.3 Distribution Strategy
11.4 Product Analysis
12. Company Profiles
12.1 William Demant Holding Group
12.2 GN Store Nord
12.3 Sonova Holding AG
12.4 Amplifon Corporate

Report Title: Global Hearing Healthcare (Hearing Aid, Hearing Implant & Hearing Diagnostic) Market Outlook 2022


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline